fbpx
RESEARCH

CRUNCHFISH: Q3 report webinar

Analys, Research

On Friday Nov 1st, 2024 Crunchfish hosted a webinar in connection with the Q3’24 report,...

Read More

TALLINK: All about the Dividend

Okategoriserade, Research

RESEARCH COLLABORATION WITH ENLIGHT RESEARCH  Q3 Sales and Profits beat estimates, but the...

Read More

CRUNCHFISH: Rights issue to stay the course on extended timeline

Analys, Research

As discussed in our previous update, Crunchfish has now settled on a path forward for the...

Read More

GRANGEX: Emerging as Europe’s top DR concentrate developer

Analys, Research

With the dust settling after the acquisition of Sydvaranger and the updated DFS for Dannemora in...

Read More

MOTION DISPLAY: Strong gross margin driving another profitable quarter  

Analys, Research

MODI reported Q2’24 sales largely in line with last year, at SEK 7.4m compared to SEK 7.6m in...

Read More

PROLIGHT: Pre-validation readout in Q4 sets stage for multicenter trial in 2025

Analys, Research

Supported by the latest troponin data generated from whole blood samples on the final commercial...

Read More

NANEXA: NEX-22 Progress, Revaluation and Financing

Analys, Research

After initiating dosing of the first patient in June with Nanexa’s long-acting depot formulation...

Read More

CRUNCHFISH: Three avenues to address the strained financing

Analys, Research

While the commercialization of Crunchfish’s solution for offline payments has shown a longer...

Read More